Citi raised the firm’s price target on Corebridge to $20 from $19 and keeps a Neutral rating on the shares. The analyst updated models in the U.S. insurance sector.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CRBG:
- Corebridge reports Q2 adjusted EPS $1.04, consensus 93c
- Corebridge to sell Laya Healthcare subsidiary to AXA for EUR 650M in cash
- Corebridge Financial, Inc. (CRBG) Q2 Earnings Cheat Sheet
- JPMorgan upgraded, JetBlue downgraded: Wall Street’s top analyst calls
- Corebridge resumed with a Neutral at Citi